Agenzia per la Tutela della Salute (ATS) di Brescia
Brescia, 25123, Italy
NCT Number: NCT07269028
Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide, accounting for approximately 903,000 deaths annually. While population-based screening programmes have demonstrated effectiveness in enhancing early detection and reducing mortality, participation rates remain suboptimal. Adherence is influenced by cognitive, psychological, and socioeconomic barriers.
This study aimed to assess the impact of a digital decision aid (DA), incorporating personalisation and gamification elements, on informed decision-making and adherence to CRC screening.
DA-CRC is a two-arm randomised controlled pilot trial. Individuals born in 1973-1974 living in the area served by the local health authority of Brescia (Northern Italy) who were invited for the first time to participate in the CRC screening programme, were eligible. An invitation letter, including instructions to download the PREVenGO app, was mailed to potential participants.
Upon download, participants were randomised to either the intervention or control arm. The intervention app included questionnaires on family history, knowledge of primary and secondary prevention, and locus of control (LoC), as well as gamification and reward features. The control app provided static educational content only. Notifications prompted users to complete follow-up assessments at 3 months (T1) and 6 months (T2), receive prevention information, and attend screening.
Looking for future studies?
Notify Me50 year–51 year
All sexes
Interventional
Not applicable
Brescia, 25123, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention app included questionnaires on family history, knowledge of primary and secondary prevention, and locus of control (LoC), as well as gamification and reward features.
Time frame: From enrollment to 6 months
Informed choice, using the three-dimensional model by Marteau, including:
Knowledge (minimum score 7/13); Attitude (score >24); Behavioural intention (actual participation).
Time frame: From enrollment to 31st December 2024
ATS Brescia provided pseudonymised data on actual FOBT participation.
Time frame: From enrollment to 6 months
Assessment through 13 multiple-choice questions. Participants were classified based on correct responses as:
Low knowledge (0-5 correct answers); Moderate knowledge (6-8); High knowledge (9-13);
Time frame: From enrollment to 6 months
Evaluation through items related to the decision-making process and perceived usefulness of the decision aid
University of Pavia
Other
Acronym: DA-CRC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718919
Colo-rectal Cancer, Colonic Diseases
Cagliari, Italy
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT04223141
Colo-rectal Cancer, Colonic Diseases
Vejle, Denmark
View Trial DetailsNCT07517848
Colo-rectal Cancer, Colonic Diseases
Manisa, Turkey (Türkiye)
View Trial Details